XML 166 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended
Aug. 24, 2021
Jul. 28, 2021
Oct. 30, 2019
Nov. 17, 2021
Nov. 30, 2021
Nov. 04, 2021
Loss Contingencies [Line Items]            
Warrants to purchase shares of common stock         131,667 250,000
Melior Pharmaceuticals [Member]            
Loss Contingencies [Line Items]            
License agreement commitments description       the Company’s timeline from 120 days to 180 days from the effective of the agreement for the Company to raise $4.0 million dollars unless, by 180 Days Adhera is in the process of completing transactions to complete the fundraising then an additional 30 Days shall be provided to allow for the completion of required fundraising    
Licensing Agreement MLR1019 [Member]            
Loss Contingencies [Line Items]            
Debt Instrument, Periodic Payment   $ 21,800,000        
Gross sales percentage   5.00%        
Option purchase percentage   10.00%        
Royalty gross sales percentage   2.50%        
Licensing Agreement MLR1019 [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Gross sales percentage 8.00%          
Licensing Agreement MLR1019 [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Gross sales percentage 1200.00%          
Licensing Agreement MLR1023 [Member]            
Loss Contingencies [Line Items]            
Debt Instrument, Periodic Payment $ 21,800,000          
License agreement commitments description if the Company failed to raise $4.0 million dollars within 120 days of the Effective Date then the License would immediately terminate unless, by 120 Days Adhera was in the process of completing transactions to complete the fundraising then an additional 30 Days would be provided to allow for the completion of the raise          
Series F Convertible Preferred Stock [Member]            
Loss Contingencies [Line Items]            
Number of shares repurchased     20      
Warrants to purchase shares of common stock     150,000      
Stock repurchase     $ 100,000      
Value of warrants held     $ 100,000